Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Synovial Sarcoma - Overview
Synovial Sarcoma - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Synovial Sarcoma - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Synovial Sarcoma - Companies Involved in Therapeutics Development
Accuronix Therapeutics Inc
Adaptimmune Therapeutics Plc
Advenchen Laboratories LLC
Apollomics Inc
Biogenera SpA
CoBioRes NV
Cue Biopharma Inc
Eli Lilly and Co
Epizyme Inc
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Immunocore Ltd
Incyte Corp
Johnson & Johnson
Karyopharm Therapeutics Inc
MediGene AG
Merck & Co Inc
Millennium Pharmaceuticals Inc
OncoTherapy Science Inc
Pfizer Inc
Shanghai GeneChem Co Ltd
Tactical Therapeutics Inc
Takara Bio Inc
Tmunity Therapeutics Inc
Xiangxue Life Sciences
Zenyaku Kogyo Co Ltd
Synovial Sarcoma - Drug Profiles
Synovial Sarcoma - Dormant Projects
Synovial Sarcoma - Discontinued Products
Synovial Sarcoma - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Synovial Sarcoma, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Synovial Sarcoma, H2 2019
Number of Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Target, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Synovial Sarcoma - Pipeline by Accuronix Therapeutics Inc, H2 2019
Synovial Sarcoma - Pipeline by Adaptimmune Therapeutics Plc, H2 2019
Synovial Sarcoma - Pipeline by Advenchen Laboratories LLC, H2 2019
Synovial Sarcoma - Pipeline by Apollomics Inc, H2 2019
Synovial Sarcoma - Pipeline by Biogenera SpA, H2 2019
Synovial Sarcoma - Pipeline by CoBioRes NV, H2 2019
Synovial Sarcoma - Pipeline by Cue Biopharma Inc, H2 2019
Synovial Sarcoma - Pipeline by Eli Lilly and Co, H2 2019
Synovial Sarcoma - Pipeline by Epizyme Inc, H2 2019
Synovial Sarcoma - Dormant Projects, H2 2019
Synovial Sarcoma - Discontinued Products, H2 2019